Portfolio
Our Investments
Actithera
A radiopharmaceutical company developing targeted cancer therapies using alpha-particle emitting radionuclides.
Oncology
Alex Therapeutics
A digital therapeutics (DTx) company based in Stockholm developing AI-powered mental health treatments.
Digital Health
ARTHEx Biotech
A Spanish biopharmaceutical company developing advanced RNA treatments for rare genetic diseases, including myotonic dystrophy type 1.
Rare Disease · RNA
Attgeno
A pharmaceutical company based in Stockholm, Sweden developing treatments for acute life-threatening conditions including pulmonary hypertension.
Cardiovascular
CardioMech
A privately-held Norwegian company developing an innovative technology to repair the mitral valve via a transcatheter approach.
Medical Device · Cardiovascular
Cardior Pharmaceuticals
A leading clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease. Acquired by Novo Nordisk in March 2024.
Complement Therapeutics
A German-headquartered biotechnology company developing complement pathway inhibitors for geographic atrophy and other conditions.
Ophthalmology
Contineum Therapeutics
A San Diego-based company focused on developing therapeutics for neurological and inflammatory diseases.
Neurology
Emergence Therapeutics
A European biopharmaceutical company advancing a nectin-4 antibody-drug conjugate for solid tumour oncology.
Oncology · ADC
Galecto
A Danish drug development company based in Copenhagen focusing on galectin biology for fibrosis and oncology.
Fibrosis · Oncology
Neuro Event Labs
A digital health company based in Tampere, Finland developing the AI-powered Nelli® seizure monitoring system. FDA 510(k) cleared.
Digital Health · Neurology
Nisonic
A medical device company from Trondheim, Norway developing advanced ultrasound technology for neurological conditions.
Medical Device · Neurology
Oncoinvent
A drug development company based in Oslo developing Radspherin®, a radiopharmaceutical for peritoneal metastases. FDA Fast Track designated.
Oncology · Radiopharmaceuticals
Ribbon Bio
Ribbon Biolabs is developing a platform technology to synthesise long, complex DNA molecules for gene therapy and synthetic biology applications.
Gene Therapy · Synthetic Biology
SAGA Diagnostics
A Lund, Sweden-based medical diagnostics company offering the Pathlight™ MRD test for ultrasensitive cancer liquid biopsies. Medicare covered.
Diagnostics · Liquid Biopsy
SciRhom
SciRhom GmbH is a German biotechnology company developing iRhom2 inhibitors for inflammatory and autoimmune diseases.
Immunology
Step Pharma
Developing novel therapeutics that inhibit the enzyme CTPS1 — the world's most advanced CTPS1 inhibitor programme in T-cell malignancies and solid tumours.
Oncology
TargED Biopharmaceuticals
A private biotechnology company developing TGD001 for targeted protein degradation in oncology. Phase 1 initiated December 2024.
Oncology · Protein Degradation
Themis Bioscience
A vaccine development company based in Vienna. Acquired by MSD in May 2020 to accelerate coronavirus vaccine development.
